US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

CRSP

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics AG

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRSP

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/11/2024	07:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference	NASDAQ:CRSP	CRISPR Therapeutics AG
13/11/2024	16:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
07/11/2024	07:00	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference	NASDAQ:CRSP	CRISPR Therapeutics AG
05/11/2024	08:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRSP	CRISPR Therapeutics AG
05/11/2024	08:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRSP	CRISPR Therapeutics AG
05/11/2024	08:01	GlobeNewswire Inc.	CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results	NASDAQ:CRSP	CRISPR Therapeutics AG
05/08/2024	16:22	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:CRSP	CRISPR Therapeutics AG
05/08/2024	15:54	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CRSP	CRISPR Therapeutics AG
05/08/2024	15:01	GlobeNewswire Inc.	CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results	NASDAQ:CRSP	CRISPR Therapeutics AG
30/05/2024	15:26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
29/05/2024	07:00	GlobeNewswire Inc.	CRISPR Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:CRSP	CRISPR Therapeutics AG
23/05/2024	07:00	GlobeNewswire Inc.	CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments	NASDAQ:CRSP	CRISPR Therapeutics AG
09/05/2024	07:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference	NASDAQ:CRSP	CRISPR Therapeutics AG
08/05/2024	15:00	GlobeNewswire Inc.	CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:CRSP	CRISPR Therapeutics AG
08/05/2024	06:00	GlobeNewswire Inc.	CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach	NASDAQ:CRSP	CRISPR Therapeutics AG
22/04/2024	15:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	NASDAQ:CRSP	CRISPR Therapeutics AG
03/04/2024	07:00	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference	NASDAQ:CRSP	CRISPR Therapeutics AG
01/04/2024	07:00	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	NASDAQ:CRSP	CRISPR Therapeutics AG
13/03/2024	07:30	GlobeNewswire Inc.	CRISPR Therapeutics Proposes New Appointment to the Board of Directors	NASDAQ:CRSP	CRISPR Therapeutics AG
21/02/2024	06:50	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CRSP	CRISPR Therapeutics AG
21/02/2024	06:30	GlobeNewswire Inc.	CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:CRSP	CRISPR Therapeutics AG
15/02/2024	15:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
15/02/2024	07:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit	NASDAQ:CRSP	CRISPR Therapeutics AG
13/02/2024	07:44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CRSP	CRISPR Therapeutics AG
13/02/2024	07:30	GlobeNewswire Inc.	CRISPR Therapeutics Announces $280 Million Registered Direct Offering	NASDAQ:CRSP	CRISPR Therapeutics AG
13/02/2024	01:30	GlobeNewswire Inc.	European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)	NASDAQ:CRSP	CRISPR Therapeutics AG
29/01/2024	15:00	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CRSP	CRISPR Therapeutics AG
16/01/2024	15:01	GlobeNewswire Inc.	CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia	NASDAQ:CRSP	CRISPR Therapeutics AG
08/01/2024	06:00	GlobeNewswire Inc.	CRISPR Therapeutics Highlights Strategic Priorities and 2024 Outlook	NASDAQ:CRSP	CRISPR Therapeutics AG
03/01/2024	07:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:CRSP	CRISPR Therapeutics AG

Showing the most relevant articles for your search:NASDAQ:CRSP

1 2 3 4 5 6 7 8 Próxima >

JP Morgan Chase

Deutsche Telekom (QX)

Financial Select Sector

US Dollar vs MXN

Health Care Select Sector

Bank of America

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones